SEC Info - Atara Biotherapeutics, Inc. - ‘DEL AM’ on 11/10/15

SEC Info℠

Home

Help

Please Sign In

Atara Biotherapeutics, Inc. – ‘DEL AM’ on 11/10/15

On: Tuesday, 11/10/15, at 5:16pm ET · Effective: 11/10/15 · Accession #: 1193125-15-373620 · File #: 333-207876

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/10/15  Atara Biotherapeutics, Inc.       DEL AM     11/10/15    1:7K                                     RR Donnelley/FA

Registration Effectiveness-Delaying Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEL AM      Registration Effectiveness-Delaying Amendment       HTML      7K

This is an HTML Document rendered as filed. [ Alternative Formats ]

DEL AM

ATARA BIOTHERAPEUTICS, INC.

701 Gateway Boulevard, Suite 200

South San Francisco, CA 94080

November 10, 2015

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re:

Atara Biotherapeutics, Inc.

Registration Statement on Form S-3 (File No. 333-207876)

Ladies and Gentlemen:

Reference is made to the Registration Statement on Form S-3 (File No. 333-207876) filed with the Securities and Exchange Commission by Atara Biotherapeutics, Inc. on November 9, 2015 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of 1933 (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement immediately following the calculation of the registration fee:

“The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to said Section 8(a), may determine.”

Sincerely,


ATARA BIOTHERAPEUTICS, INC.

By:		/s/ *Heather D. Turner*
		Heather D. Turner
		Vice President, General Counsel and Secretary

cc:	Kenneth L. Guernsey, Cooley LLP

Jodie M. Bourdet, Cooley LLP

Dates Referenced Herein and Documents Incorporated by Reference

This ‘DEL AM’ Filing	Date	Other Filings

Filed on / Effective on:	11/10/15
	11/9/15	S-3
		List all Filings

↑Top

Filing Submission 0001193125-15-373620 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Atara Biotherapeutics, Inc. – ‘DEL AM’ on 11/10/15

On: Tuesday, 11/10/15, at 5:16pm ET · Effective: 11/10/15 · Accession #: 1193125-15-373620 · File #: 333-207876

Registration Effectiveness-Delaying AmendmentFiling Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Registration Effectiveness-Delaying Amendment
Filing Table of Contents